Search results
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters via Yahoo News· 5 days agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
Advisory Panel of Experts Endorses FDA Approval of New Alzheimer's Drug - Slashdot
Slashdot· 39 minutes agoAn anonymous reader quotes a report from the New York Times: A committee of independent advisers to the Food and Drug Administration voted unanimously on Monday that the benefits outweigh the ...
Eli Lilly Is Trading At A Record High Ahead Of A Key FDA Meeting — Is It A Buy?
Investor's Business Daily· 4 days agoDonanemab works by removing built-up plaque in the brain, known as beta amyloid. Doing leads can...
FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application...
Morningstar· 2 days agoTOKYO and CAMBRIDGE, Mass., June 9, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters ...
... Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with...
Benzinga· 4 days agoThe Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biogen Inc. ("Biogen
Alzheimer’s drug from Eli Lilly wins backing of FDA committee
Washington Post· 17 hours agoAn advisory committee to the Food and Drug Administration on Monday endorsed an Alzheimer’s drug...
Unanimous FDA panel backs Lilly Alzheimer's drug
Axios· 15 hours agoIt would compete with Eisai and Biogen's Leqembi, which the FDA approved last year. The FDA called for an outside review of donanemab earlier this year...
Eli Lilly’s Alzheimer’s drug gets backing from FDA advisers
Market Watch· 17 hours agoEli Lilly & Co.’s experimental Alzheimer’s drug donanemab on Monday moved a step closer to U.S....
Novartis and others face Italy antitrust probe over eye drug
Reuters· 5 days agoSamsung Bioepis, Biogen, Genentech and Novartis, and some of their Italian, Dutch and UK units,...
Alzheimer’s drug that can slow disease gets backing from FDA advisers - The Boston Globe
The Boston Globe· 14 hours agoThe FDA approved a similar infused drug, Leqembi, from Biogen and Japanese drugmaker Eisai, last year. In a separate vote, the FDA advisers voted unanimously that the Lilly ...